Pure Health Holding PJSC

PureHealth reported a net profit of AED 1.4 billion and an EBITDA of AED 3.1 billion for the first nine months of 2024. The company's consolidated revenue increased by 56% to AED 19.0 billion, primarily driven by the Hospitals segment and supported by organic growth and acquisitions. EBITDA rose by 26% compared to the same period in 2023, with an EBITDA margin of 16.5%, indicating operational efficiencies. Net profit increased by 13% year-on-year, with a net profit margin of 7.6%. Key acquisitions included Circle Health Group and Sheikh Shakhbout Medical City, while divestments included YAS Clinics Group and Abu Dhabi Stem Cells Centre. The Hospital Segment saw revenues rise by 87% and EBITDA growth of 18%, while the Insurance Segment recorded a 17% increase in revenue and a 60% growth in EBITDA. Total assets grew by 72% to AED 48.4 billion, with a cash balance of AED 8.7 billion. The net cash position was 3.0x EBITDA, with a net cash balance of AED 6.7 billion. Overall, PureHealth demonstrated strong performance and strategic growth in the first nine months of 2024.

The text refers to the interim condensed consolidated financial statements of Pure Health Holding PJSC for the period ending on September 30, 2024.

PureHealth reported a net profit of AED 1.0 billion for the first half of 2024, with EBITDA rising to AED 2.2 billion, a 15% increase from the previous year. Consolidated revenue grew by 53% to AED 12.5 billion, driven by the Hospitals segment and supported by organic growth and acquisitions. Despite the growth, net profit decreased by 26% year-on-year due to accounting changes, finance costs from acquisitions, and corporate income tax charges, resulting in a net profit margin of 8.0%. Significant acquisitions included Circle Health Group and Sheikh Shakhbout Medical City, while the company divested its investments in YAS Clinics Group and Abu Dhabi Stem Cells Centre. The Hospitals segment saw an 83% revenue increase and 9% EBITDA growth, attributed to higher patient volumes and strategic acquisitions. The Insurance vertical, comprising Daman, reported a 15% revenue increase and a 79% rise in EBITDA, driven by higher premiums and increased membership. Total assets increased to AED 47.6 billion, with a total cash balance of AED 7.4 billion and a net cash balance of AED 5.4 billion as of June 30, 2024.

Pure Health Holding PJSC has released its interim condensed consolidated financial statements for the period ending June 30, 2024.